End-Stage Kidney Disease Resulting from Atypical Hemolytic Uremic Syndrome after Receiving AstraZeneca SARS-CoV-2 Vaccine: A Case Report.

Tawhari, Mohammed; Alhamadh, Moustafa S; Alhabeeb, Abdulrahman Yousef; Almudayfir, Ziyad; Radwi, Mansoor

Tawhari, Mohammed; Alhamadh, Moustafa S; Alhabeeb, Abdulrahman Yousef; Almudayfir, Ziyad; Radwi, Mansoor.

Afiliación

Tawhari M; College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of the National Guard Health Affairs, Riyadh 14611, Saudi Arabia.
Alhamadh MS; King Abdullah International Medical Research Centre, Ministry of the National Guard Health Affairs, Riyadh 11481, Saudi Arabia.
Alhabeeb AY; Department of Medicine, Division of Nephrology, King Abdulaziz Medical City, Ministry of the National Guard Health Affairs, Riyadh 11426, Saudi Arabia.
Almudayfir Z; College of Medicine, King Saud bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of the National Guard Health Affairs, Riyadh 14611, Saudi Arabia.
Radwi M; King Abdullah International Medical Research Centre, Ministry of the National Guard Health Affairs, Riyadh 11481, Saudi Arabia.

Vaccines (Basel) ; 11(3)2023 Mar 16.

Article en En | MEDLINE | ID: mdl-36992263

Palabras clave

AstraZeneca vaccine; COVID-19 vaccine; SARS-CoV-2 vaccine; aHUS; atypical hemolytic uremic syndrome; thrombotic microangiopathy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 1_ASSA2030 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Problema de salud: 1_doencas_transmissiveis / 4_covid_19 / 6_haemoglobinopathies_hemolytic_anaemias / 6_kidney_renal_pelvis_ureter_cancer Tipo de estudio: Prognostic_studies Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Arabia Saudita

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google